Updates from The Motley Fool

Latest updates on Cardiome Pharma Corp. (USA) from Fool.com.

Stock Performance

CRME vs. S&P 500 | 2 Year Performance
CRME 1-Day Stock Chart
CRME 5-Day Stock Chart
CRME 1-Month Stock Chart
CRME 3-Month Stock Chart
CRME 6-Month Stock Chart
CRME 1-Year Stock Chart
CRME 2-Year Stock Chart
CRME 5-Year Stock Chart
View Interactive CRME Charts
Sponsored by

Key Data Points

Primary metrics and data points about Cardiome Pharma Corp. (USA).
Current Price: $4.82
Prev Close: $4.74
Open: $4.70
Bid: $0.00
Ask: $10.82
Day's Range: $4.65 - $4.82
52wk Range: $3.70 - $10.40
Volume: 11,336
Avg Vol 60,330
Market Cap: $97.11M
P/E (ttm): -4.12
EPS (ttm): -$1.17
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Cardiome Pharma Corp. (USA).
CAPS Rating 1 out of 5
176 Outperform
29 Underperform
CAPS All Stars
36 Outperform
18 Underperform

How do you think Cardiome Pharma Corp. (USA) will perform against the market?

You pick for Cardiome Pharma Corp. (USA) is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

William Hunter, M.D., CEO

36% Approve

Based on 3 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Cardiome Pharma Corp. (USA).

Life sciences company focused on developing proprietary drugs to treat or prevent cardiovascular diseases. Current efforts are focused on the treatment of atrial arrhythmias and congestive heart failure.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers